-+ 0.00%
-+ 0.00%
-+ 0.00%

ACTUATE THERAPEUTICS - INITIATION OF PHASE 1/2 CLINICAL TRIAL WITH DAILY ELRAGLUSIB ORAL TABLET PLANNED FOR Q1 2027

Reuters·11/18/2026 13:00:03

Please log in to view news